Dosidal · Canada
NAZOPHYL DARVA
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Canada |
|---|---|
| Record | ca:authorisation:din:00166375:1106 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | ca-din: 00166375 ca-dpd-drug-code: 1106 |
| Source authority | Health Canada |
| Read date | 2026-11-15T06:54:55Z |
| authorisation status | lifecycle: history status: CANCELLED POST MARKET status_date: 1997-05-30 status_date_as_published: 30-MAY-1997 status_history: date: 1997-05-30 status: CANCELLED POST MARKET; date: 1930-12-31 status: MARKETED state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page |
| controlled status | controlled: False state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page |
| identity | atc: R05X brand_name: NAZOPHYL DARVA class: Human companies: PRODUITS FRANCAIS LABS INC. din: 00166375 drug_code: 1106 extract_set: cancelled forms: OINTMENT ingredients: ingredient: METHYLENE BLUE strength: .1014 MG; ingredient: MENTHOL strength: 177.45 MG; ingredient: EUCALYPTOL strength: .066 ML; ingredient: THYMOL strength: 27.95 MG; ingredient: CAMPHOR strength: 247 MG; ingredient: OIL OF CAJEPUT strength: .039 ML; ingredient: METHYL SALICYLATE strength: .0195 ML packaging_as_published: product_information: 50GM routes: NASAL state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page |
| prescription class | class: non_prescription schedules: NON-PRESCRIPTION DRUGS state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53y2biy6nAdX1XzMClN-h7T9281XWi3Td8NL-VSCiCgyUmiz5-7bii6TGlmGQpPw_WrVzAMSNAWJwnh8ivLh6NjAVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |